Retractable Technologies, Inc. (NYSE:RVP) CEO Acquires $17,953.60 in Stock

Retractable Technologies, Inc. (NYSE:RVP) CEO Thomas J. Shaw bought 16,030 shares of the stock in a transaction on Thursday, August 1st. The shares were bought at an average price of $1.12 per share, with a total value of $17,953.60. Following the acquisition, the chief executive officer now owns 14,571,500 shares of the company’s stock, valued at $16,320,080. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.

Retractable Technologies Stock Performance

RVP stock opened at $1.03 on Wednesday. Retractable Technologies, Inc. has a one year low of $0.87 and a one year high of $1.34. The firm has a market cap of $30.69 million, a price-to-earnings ratio of -3.94 and a beta of 2.08. The company has a debt-to-equity ratio of 0.01, a quick ratio of 8.18 and a current ratio of 11.02. The firm has a 50-day simple moving average of $1.12 and a two-hundred day simple moving average of $1.14.

Retractable Technologies (NYSE:RVP) last posted its quarterly earnings data on Wednesday, May 15th. The company reported $0.01 EPS for the quarter. Retractable Technologies had a negative net margin of 18.84% and a negative return on equity of 7.55%. The firm had revenue of $7.60 million during the quarter.

Wall Street Analysts Forecast Growth

Separately, StockNews.com assumed coverage on Retractable Technologies in a research report on Wednesday. They issued a “hold” rating for the company.

About Retractable Technologies

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.